Cargando…
The Nitric Oxide (NO) Donor Sodium Nitroprusside (SNP) and Its Potential for the Schizophrenia Therapy: Lights and Shadows
Schizophrenia is a severe psychiatric disorder affecting up to 1% of the worldwide population. Available therapy presents different limits comprising lack of efficiency in attenuating negative symptoms and cognitive deficits, typical features of schizophrenia and severe side effects. There is pressi...
Autores principales: | Zoupa, Elli, Pitsikas, Nikolaos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199342/ https://www.ncbi.nlm.nih.gov/pubmed/34073534 http://dx.doi.org/10.3390/molecules26113196 |
Ejemplares similares
-
Sodium Nitroprusside as a Nitric Oxide Donor in a Rat Intestinal Ischemia-Reperfusion Model
por: Emre, Ali, et al.
Publicado: (2008) -
Intrinsic radiosensitivity of human pancreatic tumour cells and the radiosensitising potency of the nitric oxide donor sodium nitroprusside.
por: Verovski, V. N., et al.
Publicado: (1996) -
Nitric oxide donor sodium nitroprusside-induced transcriptional changes and hypocrellin biosynthesis of Shiraia sp. S9
por: Ma, Yan Jun, et al.
Publicado: (2021) -
Sodium Nitroprusside as a Nitric Oxide Donor in a Rat Intestinal Ischemia Reperfusion Model: A Novel Molecular Mechanism
por: Namazi, Hamid
Publicado: (2008) -
The Nitric Oxide (NO) Donor Molsidomine Attenuates Memory Impairments Induced by the D1/D2 Dopaminergic Receptor Agonist Apomorphine in the Rat
por: Vartzoka, Foteini, et al.
Publicado: (2023)